In vitro and in vivo techniques used in drug development for evaluation of dose delivery of inhaled corticosteroids
Oral inhaled corticosteroids are important in the treatment of asthma since their delivery is targeted directly to the lung, which is the site of action. Triamcinolone acetonide (TAA) is an effective and safe corticosteroid that is marketed as a metered-dose inhaler (MDI) with an integrated spacer (...
Saved in:
Published in | Journal of clinical pharmacology Vol. 41; no. 1; p. 7 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.01.2001
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Oral inhaled corticosteroids are important in the treatment of asthma since their delivery is targeted directly to the lung, which is the site of action. Triamcinolone acetonide (TAA) is an effective and safe corticosteroid that is marketed as a metered-dose inhaler (MDI) with an integrated spacer (Azmacort) for the treatment of asthma. Due to the phasing out of chlorofluorocarbon (CFC) propellants, Azmacort has been reformulated with a non-CFC propellant. Due to the complexities of oral inhaled formulations and the topical nature of drug delivery to the lung for efficacy, the reformulation of oral inhaled MDIs requires careful consideration and support throughout their development, using a combination of in vitro and in vivo studies to ensure clinical comparability for both efficacy and safety. This paper describes a chronological series of studies designed to support the reformulation of Azmacort. These included in vitro studies to estimate respirable fraction, in vivo pulmonary deposition studies, in vivo pharmacokinetic-pharmacodynamic studies to estimate the systemic effects of each formulation, and final clinical studies in adult and pediatric patients to confirm the clinical comparability of the new formulation of Azmacort. The results of these studies, performed at various stages during the development of new formulations, were critical in guiding the reformulation efforts for Azmacort. |
---|---|
AbstractList | Oral inhaled corticosteroids are important in the treatment of asthma since their delivery is targeted directly to the lung, which is the site of action. Triamcinolone acetonide (TAA) is an effective and safe corticosteroid that is marketed as a metered-dose inhaler (MDI) with an integrated spacer (Azmacort) for the treatment of asthma. Due to the phasing out of chlorofluorocarbon (CFC) propellants, Azmacort has been reformulated with a non-CFC propellant. Due to the complexities of oral inhaled formulations and the topical nature of drug delivery to the lung for efficacy, the reformulation of oral inhaled MDIs requires careful consideration and support throughout their development, using a combination of in vitro and in vivo studies to ensure clinical comparability for both efficacy and safety. This paper describes a chronological series of studies designed to support the reformulation of Azmacort. These included in vitro studies to estimate respirable fraction, in vivo pulmonary deposition studies, in vivo pharmacokinetic-pharmacodynamic studies to estimate the systemic effects of each formulation, and final clinical studies in adult and pediatric patients to confirm the clinical comparability of the new formulation of Azmacort. The results of these studies, performed at various stages during the development of new formulations, were critical in guiding the reformulation efforts for Azmacort. |
Author | Gillen, M S Rhodes, G R Banerji, D D Deluccia, F Rohatagi, S Chaikin, P |
Author_xml | – sequence: 1 givenname: G R surname: Rhodes fullname: Rhodes, G R organization: Department of Drug Metabolism and Pharmacokinetics, Aventis Pharmaceuticals, Building M, Room 250, Route 202-206, P.O. Box 6800, Bridgewater, NJ 08807-0800, USA – sequence: 2 givenname: S surname: Rohatagi fullname: Rohatagi, S – sequence: 3 givenname: M S surname: Gillen fullname: Gillen, M S – sequence: 4 givenname: F surname: Deluccia fullname: Deluccia, F – sequence: 5 givenname: D D surname: Banerji fullname: Banerji, D D – sequence: 6 givenname: P surname: Chaikin fullname: Chaikin, P |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11144996$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j8tOwzAQRb0oog_4ADbIPxAYO05SL1HFo1IlNrCuHHtCjRI72E6k_j0Jj9WdOfPQvWuycN4hITcM7hirqnsAyXgFwDifymrLF2Q1s2yGS7KO8XMalqJgl2TJGBNCynJF4t7R0abgqXKG2rkZPU2oT85-DRjpEPGHmzB8UIMjtr7v0CXa-EBxVO2gkvWO-oYaH3Faae2I4TwD606qnc61D8lqHxMGb028IheNaiNe_-mGvD89vu1essPr8373cMi0YJBPxrGQDWAJdaMhRyVLnVdCotS6ZgJRlDkgAIq8qBvJCqN5DRqx0BpwK_mG3P7-7Ye6Q3Psg-1UOB__0_NvBcpe2g |
CitedBy_id | crossref_primary_10_1038_sj_jes_7500517 crossref_primary_10_1097_01_mjt_0000145357_13410_a9 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1177/00912700122009782 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
ExternalDocumentID | 11144996 |
Genre | Evaluation Studies Journal Article |
GroupedDBID | --- .55 .GJ 05W 0R~ 123 18M 1CY 1OB 1OC 29K 33P 34G 39C 3O- 3SF 4.4 52U 52V 53G 5RE 8-1 A00 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAWTL AAXRX AAYOK AAZKR ABCUV ABJNI ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACXBN ACXME ACXQS ADBBV ADBTR ADEOM ADIZJ ADMGS ADOZA ADXAS AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AHBTC AHMBA AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AUVAJ AVWKF AZFZN AZVAB BDRZF BFHJK BHBCM BMXJE BOGZA BRXPI C45 CAG CGR COF CS3 CUY CVF D-I DCZOG DPXWK DRFUL DRMAN DRSTM DU5 EBD EBS ECM EIF EJD EMOBN F5P FEDTE FUBAC G-S GODZA GWYGA H13 HF~ HGLYW HVGLF IAO IEA IHR INH INR IVC KBYEO LATKE LEEKS LH4 LOXES LSO LUTES LW6 LYRES M4V MEWTI MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N9A NPM O66 O9- OVD P2P P2W PALCI PQQKQ R.K RIWAO RJQFR ROL SAMSI SUPJJ SV3 TEORI VH1 WBKPD WH7 WIH WIJ WIK WOHZO WOIKV WPGGZ WXSBR WYJ X7M YCJ ZGI ZXP ZZTAW |
ID | FETCH-LOGICAL-c4103-27e59f0e60bfc03ea96c3749e9ccb14ee4630e00e435bf915dc2b0cee5cc0e892 |
ISSN | 0091-2700 |
IngestDate | Sat Sep 28 08:33:48 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4103-27e59f0e60bfc03ea96c3749e9ccb14ee4630e00e435bf915dc2b0cee5cc0e892 |
PMID | 11144996 |
ParticipantIDs | pubmed_primary_11144996 |
PublicationCentury | 2000 |
PublicationDate | 2001-Jan |
PublicationDateYYYYMMDD | 2001-01-01 |
PublicationDate_xml | – month: 01 year: 2001 text: 2001-Jan |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of clinical pharmacology |
PublicationTitleAlternate | J Clin Pharmacol |
PublicationYear | 2001 |
SSID | ssj0016451 |
Score | 1.6452767 |
Snippet | Oral inhaled corticosteroids are important in the treatment of asthma since their delivery is targeted directly to the lung, which is the site of action.... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 7 |
SubjectTerms | Absorption - drug effects Administration, Inhalation Adult Aerosol Propellants - administration & dosage Aerosols Anti-Inflammatory Agents - administration & dosage Anti-Inflammatory Agents - pharmacokinetics Charcoal - pharmacology Chemistry, Pharmaceutical Child Clinical Trials as Topic Drug Delivery Systems Humans Nebulizers and Vaporizers Particle Size Triamcinolone Acetonide - administration & dosage Triamcinolone Acetonide - pharmacokinetics |
Title | In vitro and in vivo techniques used in drug development for evaluation of dose delivery of inhaled corticosteroids |
URI | https://www.ncbi.nlm.nih.gov/pubmed/11144996 |
Volume | 41 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECWc9tJL0X1JW_BQ5JKoICWKto5F2ywFGgSBA-QWiFtsIJUMb0DyGf3izpCUJbsuulwEa2hINt_DaMiZNyLkvYCHUMpMngg5cIlwskzKTKikYBaCXS1V4RPt307l8YX4eplf9no_OlVLi7n6oO-26kr-B1WwAa6okv0HZFcXBQN8BnzhCAjD8a8wPqn2l-P5tI4tlOBkCZFk05V1tr-YWW8308V1I4_yyf_1Pt8YMBqsWzf2Bss0bkMfiRE8O1DzhvdFKci0HgdV8JZgdiWwnLStsFeb9eej2gRvdNTWJ57Xo3JeXo_Xtl-PUJkYqotb42d7s9A6FPUeru1S8M4uRfS8BUftG-t6XsF_YVhwo_3tzt2nl_FKPluepl6Ekna_C_hMvnu0wYcLWM3JP49u9NtuhnbITn-APvMU939iXkqKPLyDMf6bmCf3Lbw2fxf2o43X2liz-Nhl-Ig8jDjRj4FBj0nPVk_I3lmA6vaADlsR3uyA7tGzDohPyeykop5mFGhGx3iyrGlLM4o0QzvSjHZoRoFmtKUZrR1FmtGGZmiINKMbNHtGLg6_DD8dJ_FdHYkWnGUwGTYvHLOSKadZZstC6qwvCltorbiwVsiMWQYeIMuVK3hudKoYRGi51swOivQ5uVfVlX1JKHeZyR1mmI0W2sB61vGB4n2bGZMqW74iL8JkXk1CQ5arZppf_3ZklzxoWfmG3HfgAexbCCfn6p1H-CccHHZl |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+vitro+and+in+vivo+techniques+used+in+drug+development+for+evaluation+of+dose+delivery+of+inhaled+corticosteroids&rft.jtitle=Journal+of+clinical+pharmacology&rft.au=Rhodes%2C+G+R&rft.au=Rohatagi%2C+S&rft.au=Gillen%2C+M+S&rft.au=Deluccia%2C+F&rft.date=2001-01-01&rft.issn=0091-2700&rft.volume=41&rft.issue=1&rft.spage=7&rft_id=info:doi/10.1177%2F00912700122009782&rft_id=info%3Apmid%2F11144996&rft_id=info%3Apmid%2F11144996&rft.externalDocID=11144996 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-2700&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-2700&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-2700&client=summon |